Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00013247
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2001-03-14
Brief Title:
Facilitating Shared Decisionmaking About Prostate Cancer Screening
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Facilitating Shared Decisionmaking About Prostate Cancer Screening
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Due to the disputed efficacy of prostate cancer CaP screening and treatment most authorities recommend that providers inform and involve patients in CaP screening decisions
Detailed Description:
Background
Due to the disputed efficacy of prostate cancer CaP screening and treatment most authorities recommend that providers inform and involve patients in CaP screening decisions
Objectives
This study evaluated two interventions designed to facilitate this process
Methods
1152 male veterans age 50 with no CaP and primary care appointments at four VA medical facilities in VISN 23 were randomly assigned to one of three groups mailed pamphlet intervention mailed video intervention or usual care control Intervention materials were mailed two weeks prior to a target primary care appointment and patient telephone surveys were conducted one week T1 and one year T2 after the target appointment Outcomes included a 10- item validated knowledge index responses to questions on CaP natural history treatment efficacy PSA accuracy and expert disagreement about the PSA whether screening was discussed with provider scores on decision information seeking participation and satisfaction scales screening and treatment preferences and PSA testing rates
Status
Complete
Due to the disputed efficacy of prostate cancer CaP screening and treatment most authorities recommend that providers inform and involve patients in CaP screening decisions
Objectives
This study evaluated two interventions designed to facilitate this process
Methods
1152 male veterans age 50 with no CaP and primary care appointments at four VA medical facilities in VISN 23 were randomly assigned to one of three groups mailed pamphlet intervention mailed video intervention or usual care control Intervention materials were mailed two weeks prior to a target primary care appointment and patient telephone surveys were conducted one week T1 and one year T2 after the target appointment Outcomes included a 10- item validated knowledge index responses to questions on CaP natural history treatment efficacy PSA accuracy and expert disagreement about the PSA whether screening was discussed with provider scores on decision information seeking participation and satisfaction scales screening and treatment preferences and PSA testing rates
Status
Complete
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None